Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peripheral versus Central Index of Metabolic Dysfunction and Associations with Clinical and Pathological Outcomes in Alzheimer's Disease.

Journal of Alzheimer's disease : JAD - 1 Jan 2017

McLimans Kelsey E, Webb Joseph L, Anantharam Vellareddy, Kanthasamy Anumantha, Willette Auriel A

Abstract excerpt

BACKGROUND/OBJECTIVE: Insulin-like growth factor binding protein 2 (IGFBP-2) regulates blood glucose levels, facilitates hippocampal synaptic plasticity and may have a predictive value for Alzheimer's disease (AD) diagnosis. METHODS: IGFBP-2 levels were studied in plasma in 566 subjects and in cerebrospinal fluid (CSF) in 245 subjects across the AD spectrum from the Alzheimer's Disease Neuroimaging Initiative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoprotein E4

Share to Biomarkers

Share to Glucose

Share to Polymorphism, Single Nucleotide

Share to Regression Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 28968233
DOI: 10.3233/JAD-170263
PMCID: PMC5851791

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peripheral versus Central Index of Metabolic Dysfunction and Associations with Clinical and Pathological Outcomes in Alzheimer's Disease.PMID 28968233Read ↗

Spotlight on the Pathophysiological Trajectories Linked to Alzheimer’s Disease (AD): Blood-Brain Barrier (BBB); Neuroinflammation; APOE4 Allele and AD- Insulin Resistance (IR) Pathogenic LinkSemantic proximity Read ↗

Molecular landscape of the overlap between Alzheimer’s disease and somatic insulin-related diseasesSemantic proximity Read ↗

Navigation Between Alzheimer’s Disease (AD) and Its Various Pathophysiological Trajectories: The Pathogenic Link to Neuroimmunology—Genetics and NeuroinflammationSemantic proximity Read ↗

Disentangling the relationship between glucose, insulin and brain health: A UK Biobank study.Semantic proximity Read ↗

Elevated blood glucose levels are associated with the progression of brain hypometabolism, and HDL-C and<i>APOE4</i>add to this associationSemantic proximity Read ↗

Data-driven subtypes of type 2 diabetes mellitus and risk of dementia, stroke, and brain structural changes in the UK BiobankSemantic proximity Read ↗

Neuro-Metabolic and Vascular Dysfunction as an Early Diagnostic for Alzheimer’s Disease and Related DementiasSemantic proximity Read ↗

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s DiseaseSemantic proximity Read ↗

Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged AdultsSemantic proximity Read ↗

Insulin resistance in Alzheimer’s disease: The genetics and metabolomics linksSemantic proximity Read ↗

The role of insulin resistance and APOE genotype on blood-brain barrier integrity in Alzheimer's disease.Semantic proximity Read ↗

Triglyceride-Glucose Indices, Genetic Susceptibility, and Incident Dementia Risk Across Early CKM Syndrome Stages: A UK Biobank Prospective Cohort StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.